Incubators & VCs Value proposition
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Knowledge Transfer, R&D, Licensing, Partnerships, European & International Research Projetcs, Public Health, techtransfert, valorisation, lifescience, and biotechnologyOriginal language
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Inserm Transfert - Accueil
Inserm Transfert, fondée en 2000, est la filiale privée de l’Inserm spécialisée dans le transfert de technologies en sciences de la vie
http://www.inserm-transfert.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Agence du numérique en santé | Other 15 Apr 2024 | | |
 Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Other 30 Nov 2022 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 22 Jan 2021 | | |
 | Aquitaine Science Transfert (SATT Aquitaine) | Other 10 Apr 2024 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 20 Sep 2023 | | |
 AUDACIA Startup accelerator & VC, Financial Services | AUDACIA Startup accelerator & VC, Financial Services | Other 7 Feb 2023 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 16 Nov 2022 15 Apr 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 12 Jan 2023 | | |
 CEA Research | CEA Research | Other 23 Sep 2021 12 Oct 2023 | | |
 Clermont Auvergne Innovation Research, Research Services | Clermont Auvergne Innovation Research, Research Services | Other 3 Feb 2023 | | |